Breaking News on Pharmaceutical Technology

Product news > Drug delivery systems

Latest news headlines

Products

Suppliers

Luitpold buys PharmaForce for generic injectables

07-Jan-2010 - Daiichi-Sankyo subsidiary Luitpold Pharmaceuticals has acquired PharmaForce, giving it a 40,000 sq ft cGMP compliant sterile manufacturing facility and a 20,000 sq ft API production plant.

MPI and Bioject form needle-free pact

06-Jan-2010 - US preclinical CRO MPI Research has formed an alliance with Oregon-based needle-free delivery specialist Bioject Medical Technologies.

News in brief

CyDex awarded additional Captisol patent

06-Jan-2010 - The US PTO has granted CyDex new patent for the production of ultra high-purity modified cyclodextrin.

Flexible artificial blood cells could improve drug delivery, says US group

17-Dec-2009 - Artificial red blood cells (RBC) that mimic “biologically optimised” characteristics could better nanotech drug delivery, say US scientists.

US PTO approves Isis and Alnylam’s new RNAi claims

16-Dec-2009 - US drugmakers developers Isis and Alnylam say the US PTO has allowed 75 new claims relating to the development of RNAi drugs.

Sanofi boosts syringe and vacc capacity at French plant

15-Dec-2009 - Sanofi Aventis has revamped operations at its sterile injectables plant in Le Trait, France, adding three new production units that double syringe making capacity and diversify its vaccine manufacturing capability.

GSK and Intercell team on patch that could make H5N1 vacc go further

14-Dec-2009 - Intercell’s needle-free patch delivery technology has the potential to change the way vaccines are delivered, according to Jean Stephenne, president of GSK Biologicals.

Sanofi to supply insulin to Generex

10-Dec-2009 - Sanofi-Aventis will manufacture and supply recombinant human insulin crystals to Generex Biotechnology for use in Oral-lyn commercial production and clinical trials.

Merrimack buys drug delivery business Hermes

09-Dec-2009 - Hermes Biosciences has been acquired by Merrimack Pharmaceuticals in a deal which aims to combine the companies’ drug discovery and delivery platforms to develop cancer treatments.

US FDA clears “first-ever” 24hr liquid SR drug

08-Dec-2009 - FDA approval for a 24-hour liquid sustained-release formulation could significantly improve tailored dosing, according to US developer Tris Pharma.

Terapio lands $5m to develop delivery tech

01-Dec-2009 - Terapio has secured $5m (€3.3m) in funding to develop RLIP76, which is being used to counteract radiation and deliver large molecules across cell membranes, such as genetic material across the BBB.

Unilife files US patents for “world first” RTF vacc syringe; mulls Nasdaq listing

30-Nov-2009 - Unilife Medical Solutions has filed US patents for Unifill Select, which it claims is the first ready-to-fill (RTF) syringe specifically designed for vaccine delivery.

Cafosa launches gum delivery excipient

17-Nov-2009 - Spanish ingredient supplier Cafosa has launched a new directly compressible pharmaceutical excipient for medicated chewing gums that, it claims, can boost patient compliance.

News in brief

GSK teams up with Nabi on NicVax

17-Nov-2009 - GSK has signed a $540m (€362m) licensing agreement with Nabi Biopharmaceuticals for the Phase III candidate nicotine vaccine, NicVAX.

Six Pfizer-Wyeth R&D sites to close post merger

10-Nov-2009 - Pfizer will close six R&D facilities in the US and the UK, reducing its global capacity by over a third following completion of its acquisition of Wyeth.

West laying off 100 staff

04-Nov-2009 - West Pharmaceutical Services is laying off 100 staff as part of restructuring efforts after its third quarter results fell short of expectations, despite operating profit increasing by 45 per cent.

Genzyme targets BBB

04-Nov-2009 - Genzyme is evaluating to-BBB’s G-Technology as part of a research collaboration aimed at developing treatments capable of crossing the blood-brain barrier (BBB).

Work begins on Indian seasonal flu vacc plant

29-Oct-2009 - Novavax says its new Indian vaccine plant will be operational in four months with sufficient capacity to help meet local demand for seasonal influenza vaccines.

News in brief

Unilife tagets pharma with Unifill brand

28-Oct-2009 - US headquartered Unilife is targeting pharmaceutical companies with its new Unifill RTF safety syringe and product range and has begun seeking international trademarks.

3Ms Drug delivery sales slide in comparison with strong 2008

27-Oct-2009 - Drug delivery device sales for Q3 were one of the few low points for 3M’s healthcare business, falling 5 per cent year on year.

Valois discusses what patients want from a device

20-Oct-2009 - Patients want nasal delivery devices that are portable, hygienic and can be used discretely, according to a director at Valois who delivered a talk on the company’s side-actuated product at CPhI 2009.

News in brief

Schott plans 24/7 RTF syringe production at US plant

19-Oct-2009 - The US arm of packaging giant Schott has added ready-to-fill (RTF) glass syringe manufacturing capacity at its facility in Lebanon, Pennsylvania in a $14m (€9.4m) expansion designed to meet growing demand.

Critical gains funding for hGH nasal delivery

19-Oct-2009 - Critical Pharmaceuticals has received a £1.5m ($2.4m) award to develop its hGH nasal spray, the market for which could be sizeable as company’s attempt to differentiate in response to generic competition.

CPhI 2009 - Road to recovery?

15-Oct-2009 - As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success.

CPhI 2009 show preview

08-Oct-2009 - We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.

Sign up for your free newsletter